Kestra Medical Technologies, Ltd. Common Stock (KMTS)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $1.67B
Last updated: Nov 17, 2026 at 4:15 PM ET
Kestra Medical Technologies, Ltd. Common Stock (KMTS) Statistics
Kestra Medical Technologies, Ltd. Common Stock (KMTS) has a market cap of $1.67B and an enterprise value of $1.67B. Its share count is up 14.15% from a year earlier.
Total Valuation
Enterprise value is 0.24% above the market cap, as debt exceeds cash.
| Market Cap | $1.67B |
|---|---|
| Enterprise Value | $1.67B |
| Latest price (Nov 17, 2026) | $28.27 |
Key Dates
The next earnings report is set for Dec 10, 2026.
| Next Earnings Date | Dec 10, 2026 |
|---|---|
| Last Earnings Date | Sep 14, 2026 |
| Fiscal Year End | April |
Valuation Ratios
Sales and book value multiples are 15.5x and 7.4x.
| P/S Ratio | 15.5x |
|---|---|
| Forward P/S | 11.8x |
| P/B Ratio | 7.4x |
Price Statistics
The stock is up 12.99% over 52 weeks and trades 2.84% above its 50-day average.
| Beta (1Y) | 1.59 |
|---|---|
| 52-Week Change | +12.99% |
| 1-Month Change | -3.75% |
| 3-Month Change | +1.29% |
| 6-Month Change | +42.78% |
| Total Return (1Y) | +12.99% |
| Return vs SPY (1Y) | -1.34% |
| Max Drawdown (1Y) | -36.20% |
| Sharpe Ratio (1Y) | 0.15 |
| Correlation with SPY (1Y) | 0.34 |
| 50-Day Average | $27.49 |
| 200-Day Average | $24.11 |
| 52-Week Range | $17.34 to $31.99 |
| RSI (14 Days) | 48.3 |
| Average Volume (20 Days) | 529.15K |
Financial Position
Current assets cover 4.69x current liabilities, and total debt is 0.33x shareholder equity.
| Current Ratio | 4.69x |
|---|---|
| Quick Ratio | 4.53x |
| Debt / Equity | 0.33x |
| Interest Coverage | -10.38x |
Returns and Efficiency
Return on invested capital is -48.84% and return on equity is -67.40% over the last 12 months.
| Return on Equity (ROE) | -67.40% |
|---|---|
| Return on Assets (ROA) | -43.15% |
| Return on Invested Capital (ROIC) | -48.84% |
| Inventory Turnover | 6.96x |
| Receivables Turnover | 7.13x |
| Cash Conversion Cycle | -94 days |
Scores
KMTS has an Altman Z-Score of 4.70, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 4.70 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Balance Sheet
Shareholder equity funds 64.01% of the $347.36M in total assets.
| Cash and Equivalents | $68.56M |
|---|---|
| Total Debt | $72.50M |
| Net Debt | $3.94M |
| Net Debt Per Share | $0.07 |
| Working Capital | $178.00M |
| Shareholder Equity | $222.36M |
| Book Value Per Share | $3.80 |
| Total Assets | $347.36M |
| Total Liabilities | $125.00M |
Balance sheet as of Jul 31, 2026.
Cash Flow
After $35.06M of capital spending, operating cash flow left -$122.78M of free cash flow.
| Operating Cash Flow | -$87.72M |
|---|---|
| Capital Expenditures | $35.06M |
| Free Cash Flow | -$122.78M |
| FCF Per Share | -$2.06 |
| Depreciation and Amortization | $10.66M |
Trailing 12 months through Jul 31, 2026.
Peer Position
Against 11 similar companies, KMTS has the 2nd highest P/S.
P/S RatioPeer median 3.4x
ROICPeer median 7.13%
| P/S Ratio | 15.5x vs 3.4x median |
|---|---|
| ROIC | -48.84% vs 7.13% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About KMTS
What is KMTS's market cap?
Kestra Medical Technologies, Ltd. Common Stock has a market cap of $1.67B. Its enterprise value, which adds debt and subtracts cash, is $1.67B.
How many shares of KMTS are outstanding?
Kestra Medical Technologies, Ltd. Common Stock has 58.57M shares outstanding. The count is up 14.15% from a year earlier.
Does KMTS pay a dividend?
No. Kestra Medical Technologies, Ltd. Common Stock does not pay a dividend.
How much debt does KMTS have?
Kestra Medical Technologies, Ltd. Common Stock has $72.50M of total debt and $68.56M of cash and equivalents, a net debt position of $3.94M.
KMTS pages: Overview, Forecast, Financials, Statistics, Competitors